Global Healthcare Contract Manufacturing Market Size By End-Use Industry (Pharmaceutical, Medical Device), By Service Type (Pharmaceutical Contract Manufacturing, Medical Devices Contract Manufacturing), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Healthcare Contract Manufacturing Market Size By End-Use Industry (Pharmaceutical, Medical Device), By Service Type (Pharmaceutical Contract Manufacturing, Medical Devices Contract Manufacturing), By Geographic Scope And Forecast
Healthcare Contract Manufacturing Market Size And Forecast
Healthcare Contract Manufacturing Market size was valued at USD 222,965.40 Million in 2021 and is projected to reach USD 493,531.50 Million by 2030, growing at a CAGR of 9.23% from 2023 to 2030.
Pharmaceutical and medical device manufacturers outsource low-cost services to third parties (CMOs) to reduce overall manufacturing costs and shorten time to market leading to growing supply to cater to the demand. Also, COVID-19 has brought unprecedented demand for diagnostic tests, personal protective equipment (PPE), ventilators, and other critical medical supplies. The Global Healthcare Contract Manufacturing Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Healthcare Contract Manufacturing Market Definition
Healthcare Contract Manufacturing is also called platinum practice, boutique medicine, concierge care, and direct Pharmaceutical. Healthcare Contract Manufacturing is an emerging business model in the healthcare industry that mostly focuses on creating a connection between the healthcare provider and the patient.
In this field, patients are required to pay their fees on an annual and monthly basis in exchange for doctors committing to provide or help improve care and to care for only a limited number of patients. In addition, health insurance companies forced healthcare providers to consult more patients for lower margins. This led to increased patient volume, leading to physician burnout, misdiagnosis, patient dissatisfaction, and limited access to Pharmaceutical facilities.
Global Healthcare Contract Manufacturing Market Overview
The presence of end-to-end service providers engaged in providing value-added services for an integrated or risk-sharing business model is expected to fuel market growth. Pharmaceutical and medical device manufacturers outsource manufacturing activities to CMOs to reduce their manufacturing footprint. It enables manufacturers to be more dynamic and cost-effective in their production process. In addition, factors such as the increasing prevalence of non-invasive surgical procedures are driving the demand for pharmaceutical drugs and medical devices.
To meet this increased demand, OEMs outsource the production of ancillary manufacturing activities as it helps them reduce labor costs, free up capital, increase worker productivity and improve production times. For many large, medium, and small pharma firms, outsourcing is proving to be an economical option as the fixed costs of manufacturing biologics account for approximately 60-70% of the cost of goods sold (COGS) and cannot be avoided even in idleness.
COVID-19 has brought unprecedented demand for diagnostic tests, personal protective equipment (PPE), ventilators, and other critical medical supplies. COVID-19 has had a major impact on the supply-demand gap, with a 1,000-2,000-fold increase in PPE products, raw material shortages have increased by more than 10%, increasing by more than 100% in 2020. The COVID-19 pandemic has forced many pharmaceutical and medical device companies to increase the production of drugs and medical devices needed by infected patients around the world. The US FDA found that more than 60% of FDA-regulated products imported from China are medical devices, making the US medical device industry highly dependent on the Chinese supply chain. Medical device manufacturers are facing severe supply bottlenecks, which will ultimately reduce the company’s revenue generation scope.
Global Healthcare Contract Manufacturing MarketSegmentation Analysis
The Global Healthcare Contract Manufacturing Market is Segmented on the basis of End-Use Industry, Service Type, and Geography.
Healthcare Contract Manufacturing Market, By End-Use Industry
Pharmaceutical
Medical Device
Biopharmaceuticals
Based on End-Use Industry, the market is bifurcated into Pharmaceutical, Medical Device, and Biopharmaceuticals. The medical devices segment is expected to dominate the contract manufacturing market over the forecast period due to increasing outsourcing of equipment manufacturing due to the lack of in-house manufacturing facilities and complexity. On the basis of therapeutic areas, the medical devices segment is analyzed for cardiology, medical imaging, orthopedics, IVD, ophthalmic, general and plastic surgery, drug delivery, dentistry, and other areas.
Healthcare Contract Manufacturing Market, By Service Type
Pharmaceutical Contract Manufacturing
Medical Devices Contract Manufacturing
Based on Service Type, the market is bifurcated into Pharmaceutical Contract Manufacturing and Medical Devices Contract Manufacturing. The medical devices segment had the largest share in 2021. The increasing demand for medical devices due to increasing cases of associated conditions is attributed to the growth of outsourcing these devices. In addition, the high complexity of cardiovascular devices and the need for technical knowledge lead to higher outsourcing of these devices.
Healthcare Contract Manufacturing Market, By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
On the basis of Regional Analysis, The Global Healthcare Contract Manufacturing Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific (APAC) accounted for the largest revenue share in 2021 and is expected to remain dominant during the forecast period due to increasing demand for advanced products is another major factor driving the industrial scale. Original equipment manufacturers (OEMs) outsource medical device manufacturing activities to third parties, especially in developing countries, to gain economic benefits. In addition, these regions are witnessing increasing cases of chronic diseases such as heart disorders, which is positively impacting the growth of the market.
Changes in reimbursement systems are some of the main factors expected to increase the adoption of cost-containment measures by OEMs. So that reimbursement issues do not affect financial goals, device manufacturers develop a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early stages of product development. Additionally, The growth of the US market is driven by the growing demand for advanced and effective medical devices. Also, growth in healthcare expenditure, medical requirements of an aging population, and a number of surgical procedures are some of the driving factors for the growth of the market.
Key Players
The “Global Healthcare Contract Manufacturing Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Nordson Corporation, Integer Holdings Corporation, Jabil Inc., Viant Technology LLC, FLEX LTD., Celestica Inc., Sanmina Corporation, Plexus Corp., Phillips-Medisize, West Pharmaceutical Services, Inc., Synecco.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Key Developments
In June 2022, Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical teamed up to offer an innovative and rapid turnaround process for 3D-printed medical devices.
In May 2022, Biomerics, one of the leading vertically integrated medical device contract manufacturers serving the interventional device market, opened a 2,000-square-foot balloon and balloon catheter center of excellence in Galway. This is Biomerics’ first facility in Europe and the second facility outside the United States after Costa Rica.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Healthcare Contract Manufacturing Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in Global Healthcare Contract Manufacturing Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Healthcare Contract Manufacturing Market Size By End-Use Industry (Pharmaceutical, Medical Device), By Service Type (Pharmaceutical Contract Manufacturing, Medical Devices Contract Manufacturing), By Geographic Scope And Forecast